BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Blog Main Image - 3D People Cubes Connected String Grey
News

New Living BioBank Matches Diabetes Patients with Researchers

Read More
News Main Image - Current Biology
Press Release

Chitin, a Structural Molecule Associated with Allergy Response in Mammals is Identified in Vertebrates

Read More
News Main Image - Journal New England Journ of Med NEJM
News

Early Consumption of Peanuts Prevents Peanut Allergy in High-Risk Infants

Read More
Blog Main Image - BRI Building Rear
Press Release

Benaroya Research Institute Welcomes Three New Board Members

Read More
News Main Image - Seattle Magazine
News

Immunotherapy Research is Rebooting Seattle's Biotech Sector

Read More
News Main Image - American Diabetes Association ADA
News

Developing Disease-Modifying Therapies for Children with Type 1 Diabetes

Read More
News Main Image - Diabetes Care
News

One in Every Three People with Type 1 Diabetes Produces Insulin Years Post-Diagnosis

Read More
News Main Image - Seattle Business
News

Learn about Immunotherapy and BRI's Work in Seattle Business Magazine

Read More
News Main Image - Medical Daily
News

Food Allergy Development Linked to Skin Exposure - New Study from Steven Ziegler, PhD

Read More
News Main Image - JDRF
News

BRI to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question

Read More
Press Release

Benaroya Research Institute to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question

Read More
Blog Main Image - Researcher Woman Examining Samples Blue
News

BRI Receives $2.2 Million to Discover Biomarker that Triggers Allergies

Read More
Press Release

Benaroya Research Institute Receives $2.2 Million to Discover Biomarker That Triggers Allergies

Read More
News Main Image - Accelerator
News

Accelerator Corporation Secures $51.1 Million to Support Research

Read More
News Main Image - Immune Tolerance Network ITN
Press Release

Immune Tolerance Network’s TrialShare Recognized for Using Data for Public Good

Read More